Inactive Instrument

Notis Global, Inc.

NGBL

US66980B1008

Medbox, Inc. Announces resignation of Matt Feinstein as Director

October 31, 2014 at 10:49 am

On October 30, 2014, Matt Feinstein resigned as a director of Medbox, Inc. Mr. Feinstein will remain an employee of the company, serving as a Vice President.

Latest news about Notis Global, Inc.

Notis Global, Inc. Announces Board Resignations	20-03-26	CI
Notis Global, Inc. Announces Resignation of Andrew Kantarzhi from the Board of Directors	20-02-14	CI
Notis Global, Inc. Announces Resignation of Charles K. Miller from the Board of Directors	20-01-17	CI
Notis Global, Inc. Enters into Partner Farm Agreement and Supply Agreement with Mile High Labs, Inc	19-05-16	CI
Notis Global, Inc. Announces Executive Changes	17-08-23	CI
Notis Global, Inc. Approves Management Changes	17-07-17	CI
Notis Global, Inc Announces Management Changes	17-05-25	CI
Notis Global, Inc. announced that it has received $1.318599 million in funding from Magic Farms, LLC	16-12-14	CI
Notis Global Inc. Announces Earnings Results for the Second Quarter Ended June 2016	16-10-23	CI
Notis Global, Inc. announced that it expects to receive $0.05 million in funding	16-10-09	CI
Notis Global, Inc. announced that it expects to receive $2 million in funding from Magic Farms, LLC	16-09-29	CI
Notis Global, Inc. announced that it has received $1.431 million in funding	16-09-29	CI
Notis Global, Inc. announced that it expects to receive $1.5 million in funding	16-06-29	CI
Notis Global, Inc. announced that it has received $0.12 million in funding	16-06-21	CI
C. Douglas Mitchell to Resign as Chief Financial Officer of Notis Global, Inc. on May 31, 2016	16-05-27	CI
Notis Global, Inc. announced that it has received $1.13 million in funding	16-05-22	CI
Notis Global, Inc. announced that it expects to receive $1.13 million in funding	16-05-19	CI
Notis Global, Inc. announced that it expects to receive $0.23 million in funding from Yorkville Advisors, LLC	16-04-12	CI
Notis Global, Inc. will Change its Ticker to NGBL from MDBX	16-03-21	CI
Notis Global and EWSD I, LLC Enters First Amended and Restated Farming Agreement with Whole Hemp Company	16-03-17	CI
Notis Global, Inc. announced that it has received $0.1275 million in funding from Chicago Venture Partners, L.P.	16-03-14	CI
Notis Global, Inc. announced that it has received $0.03 million in funding.	16-03-14	CI
Notis Global, Inc. announced that it expects to receive $0.25 million in funding from Chicago Venture Partners, L.P.	16-03-13	CI
Notis Global, Inc. announced that it has received $0.03 million in funding.	16-03-09	CI
Notis Global, Inc. announced that it has received $0.03 million in funding.	16-03-03	CI

Notis Global, Inc. is engaged in the cultivation of hemp and production of hemp-based products. The Company owns and manages real estate for the cultivation of hemp in the United States. The Company manufactures and markets hemp products and cannabidiol (CBD) oil. It manages the entire supply chain from farming and extraction of hemp, through to sale of hemp products in the market.

Sector

Pharmaceuticals

More about the company

Sector Alternative Medicine

	1st Jan change	Capi.
DONG-E-E-JIAO CO.,LTD.	+37.29%	6.09B
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.	-21.28%	4.14B
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED	+4.52%	3.23B
TASLY PHARMACEUTICAL GROUP CO., LTD	-18.16%	2.83B
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD.	-7.70%	2.39B
HENAN LINGRUI PHARMACEUTICAL CO., LTD.	+41.50%	1.9B
TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD.	-4.05%	1.57B
GUANGYUYUAN CHINESE HERBAL MEDICINE CO., LTD.	-15.56%	1.55B
TIANJIN CHASE SUN PHARMACEUTICAL CO.,LTD	-14.62%	1.5B

Alternative Medicine